Skip to main content
. 2023 Jan 11;10:990008. doi: 10.3389/fped.2022.990008

Table 1.

Laboratory examination results at admission.

Test items (reference values) Results Test items (reference values) Results
Blood routine test Autoimmune antibody
White blood cell (4.00–10.00 × 109/L) 9.98 ANA (0.00–12.00 U/ml) 33.3
Neutrophils (1.80–6.40 × 109/L) 6.07 P-ANCA Weakly positive
Hemoglobin (120–140 g/L) 104 C-ANCA Negative
Platelet (100–300 × 109/L) 371 ANCA-MPO Negative
Acute-phase reactants ANCA-PR3 Negative
PCT (0.00–0.05 ng/ml) 0.43 HLA-B27 Negative
C-reactive protein (0.00–10.00 mg/L) 75.50 SAA (0.00–6.40 mg/L) 675
ESR (0.00–20.00 mm/h) 25 RF (0.00–20.00 Ku/L) 12.30
Cytokine assay Thyroid function
IL-2 (0.00–5.71 pg/ml) 1.22 T3, T4, FT3, FT4 Normal
IL-4 (0.00–2.80 pg/ml) 3.34 TG-AB (≤3.99 IU/ml) 20.2
IL-6 (0.00–5.30 pg/ml) 15.35 TPO-Ab (≤9.00 IU/ml) 439.2
IL-17 (0.00–20.60 pg/ml) 14 Pathogenic examination
TNF(0.00–4.60) 3.22 CMV-DNA (0–500 copies/ml) Negative
IFN-γ (pg/ml) 4.61 Influenza virus antigen Negative
Cellular immunization EB-VCA-IgG (0.00–20.00 U/ml) >750
CD19+ (7.0%–18.0%) 19.4 EB-VCA-IgM (0.00–40.00 U/ml) 12.70
CD3+ (620%–76.0%) 71.7 EB-VCA-IgA (0.00–10.00COI) 0.04
CD3+CD4+ (32.0%–46.0%) 34.5 EBV-DNA (0–500 Copies/ml) Negative
CD3+CD8+ (18.0%–32.0%) 28.5 ASO (0.00–160.00 Ku/L) 228
NK cell (7.0%–18.0%) 8.3 Immunoglobulins
Complements IgE (0.00–120.00 IU/ml) 234.80
C3 (0.79–1.17 g/L) 1.28 IgA (1.45–3.45 g/L) 1.47
C4 (0.17–0.31 g/L) 0.28 IgG (10.13–15.13 g/L) 19.3
IgM (0.92–2.04 g/L) 1.82

ANA, antinuclear antibodies; ESR, erythrocyte sedimentation rate; ANCA, anti-neutrophilic cytoplasmic antibodies; PR3, proteinase 3; MPO, myeloperoxidase; HLA-B27, human leukocyte antigen B27; SAA, serum amyloid A protein; RF, rheumatoid factor; TG-AB, thyroglobulin antibodies; TPO-Ab, thyroid peroxidase antibody; ASO, anti-streptolysin O; PCT, procalcitonin; IL, interleukin; TNF, tumor necrosis factor; IFN-γ, gamma-interferon. EB, Epstein-Barr; EBV, Epstein-Barr virus; VCA, viral capsid antigen; CMV, cytomegalovirus.